Nuclear medicine and clinical oncology | Gemmell (2026) | Neurology | Zadegan et al. (2026) | Haematology and genetic epidemiology | Da Silva Faria et al. (2026), preprint

Introduction | How this differs from a single optimal cut-point | The data | 1. Data preparation | 2. How many cut-points? | 3. Where are the boundaries? | 4. Are the boundaries stable? | Reading the tier | 5. Results at 500 replicates | 6. Reporting | Group composition | Hazard ratios and diagnostics | Joint stability | 7. Conclusion | Reference

Introduction | The data | 1. Setup | 2. Data preparation | 3. Finding the cut-points | How many? | Where? | 4. Stability | Results at 500 replicates | 5. Reporting and diagnostics | Group composition | Hazard ratios | Proportional hazards | Landmark analysis | Survival curves | 6. Conclusion | References